| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 4.44e-11 | 14 | 212 | 7 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.19e-07 | 46 | 212 | 7 | GO:0005245 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | KCND2 KCNG1 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 5.32e-06 | 152 | 212 | 10 | GO:0022843 |
| GeneOntologyMolecularFunction | calcium channel activity | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 9.86e-06 | 129 | 212 | 9 | GO:0005262 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | KCND2 KCNG1 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 2.58e-05 | 182 | 212 | 10 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | KCND2 KCNG1 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 2.83e-05 | 184 | 212 | 10 | GO:0022832 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.36e-05 | 18 | 212 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 3.47e-05 | 151 | 212 | 9 | GO:0015085 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | RPP21 DARS1 ARID1A ALKBH5 ZRANB3 PNPT1 DNMT3L SMG6 TRMT9B MRM2 YBEY POLA1 NOB1 POLRMT DIS3 AARSD1 TFB1M TRMT44 CHTF18 | 6.19e-05 | 645 | 212 | 19 | GO:0140640 |
| GeneOntologyMolecularFunction | selenide, water dikinase activity | 1.12e-04 | 2 | 212 | 2 | GO:0004756 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, paired acceptors | 1.12e-04 | 2 | 212 | 2 | GO:0016781 | |
| GeneOntologyMolecularFunction | glycylpeptide N-tetradecanoyltransferase activity | 1.12e-04 | 2 | 212 | 2 | GO:0004379 | |
| GeneOntologyMolecularFunction | peptidyl-lysine N6-myristoyltransferase activity | 1.12e-04 | 2 | 212 | 2 | GO:0018030 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | RPP21 DARS1 ALKBH5 PNPT1 SMG6 TRMT9B MRM2 YBEY NOB1 POLRMT DIS3 AARSD1 TFB1M TRMT44 | 1.56e-04 | 417 | 212 | 14 | GO:0140098 |
| GeneOntologyMolecularFunction | nuclease activity | 1.88e-04 | 231 | 212 | 10 | GO:0004518 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.68e-04 | 118 | 212 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 3.34e-04 | 3 | 212 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | RPS6KA1 LRRK2 PNPT1 BMPR1A TAOK3 PANK2 NRK DLG2 DMPK PIM2 POLA1 TENT5A ROR2 POLRMT BAZ1B SEPHS2 SEPHS1 CDK13 PRKCI PKN1 MAST3 EPHA8 | 4.30e-04 | 938 | 212 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 6.33e-04 | 136 | 212 | 7 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 6.33e-04 | 136 | 212 | 7 | GO:0004519 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO1G SPIRE2 PHACTR2 TRAF3IP1 MYO7A CENPF PSG6 LRRK2 MAP1LC3A SHROOM4 DLG4 KIFC3 CACNA1C CACNA1D KIF21A DNM1L CLIP3 EEF2 FHOD1 PHACTR3 CORO6 REEP4 CAPZA3 PHACTR1 | 6.52e-04 | 1099 | 212 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 6.94e-04 | 100 | 212 | 6 | GO:0019888 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.90e-04 | 70 | 212 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | gated channel activity | RYR3 KCND2 KCNG1 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 9.24e-04 | 334 | 212 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | tRNA (uridine) methyltransferase activity | 1.10e-03 | 5 | 212 | 2 | GO:0016300 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.10e-03 | 5 | 212 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | RYR3 KCND2 KCNG1 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 1.14e-03 | 343 | 212 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 1.31e-03 | 113 | 212 | 6 | GO:0019208 | |
| GeneOntologyMolecularFunction | kinase activity | RPS6KA1 LRRK2 BMPR1A TAOK3 PANK2 NRK DLG2 DMPK PIM2 ROR2 BAZ1B SEPHS2 SEPHS1 CDK13 PRKCI PKN1 MAST3 EPHA8 | 1.37e-03 | 764 | 212 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.64e-03 | 6 | 212 | 2 | GO:1905030 | |
| GeneOntologyMolecularFunction | microtubule binding | SPIRE2 TRAF3IP1 CENPF LRRK2 MAP1LC3A KIFC3 KIF21A DNM1L CLIP3 REEP4 | 1.74e-03 | 308 | 212 | 10 | GO:0008017 |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.86e-03 | 210 | 212 | 8 | GO:0019903 | |
| GeneOntologyMolecularFunction | actin binding | MYO1G SPIRE2 PHACTR2 MYO7A PSG6 LRRK2 SHROOM4 EEF2 FHOD1 PHACTR3 CORO6 CAPZA3 PHACTR1 | 1.90e-03 | 479 | 212 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | phosphatase binding | 2.11e-03 | 264 | 212 | 9 | GO:0019902 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | 2.27e-03 | 7 | 212 | 2 | GO:0008467 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | PHACTR2 PDGFB RPS6KA1 LRRK2 GAS6 ARHGAP11A CAVIN4 TAOK3 UBE2N FNIP1 C5 DENND5A DMPK DOCK6 PREX1 RASAL1 DNMT3L PPP4R1 COL6A3 DNM1L DIS3 SERPINA12 PPP4R4 ARHGAP5 ARHGAP12 PHACTR3 PHACTR1 | 2.28e-03 | 1418 | 212 | 27 | GO:0030234 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G MYO7A SMC1A ARID1A ZRANB3 ABCB4 KIFC3 DNAH6 DYNC1H1 SLC27A5 HYOU1 KIF21A DNAH2 CHTF18 ABCB11 | 2.42e-03 | 614 | 212 | 15 | GO:0140657 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 5.30e-07 | 48 | 210 | 7 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 5.30e-07 | 48 | 210 | 7 | GO:1902656 | |
| GeneOntologyBiologicalProcess | calcium ion import | PDGFB FCRL3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 7.12e-07 | 98 | 210 | 9 | GO:0070509 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | RYR3 APLNR CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 8.03e-05 | 217 | 210 | 10 | GO:0097553 |
| GeneOntologyBiologicalProcess | selenocysteine biosynthetic process | 1.03e-04 | 2 | 210 | 2 | GO:0016260 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-glycine N-myristoylation | 1.03e-04 | 2 | 210 | 2 | GO:0018008 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S SLC9A5 | 1.06e-04 | 142 | 210 | 8 | GO:0098659 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S SLC9A5 | 1.06e-04 | 142 | 210 | 8 | GO:0099587 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.47e-07 | 46 | 209 | 7 | GO:0005891 | |
| GeneOntologyCellularComponent | calcium channel complex | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 6.72e-07 | 73 | 209 | 8 | GO:0034704 |
| GeneOntologyCellularComponent | cation channel complex | RYR3 KCND2 KCNG1 DLG2 DLG4 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 4.61e-06 | 235 | 209 | 12 | GO:0034703 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | TRAF3IP1 CENPF LRRK2 CFAP54 DLG2 DLG4 DNAH6 DYNC1H1 CCDC40 EFCAB6 DNAH2 ABHD13 | 8.83e-05 | 317 | 209 | 12 | GO:0032838 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | RYR3 KCND2 KCNG1 DLG2 DLG4 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 1.18e-04 | 378 | 209 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | sarcolemma | RYR3 GHRHR CAVIN4 KCND2 CACNA1H CACNA1C CACNA1D CACNA1S COL6A3 | 1.30e-04 | 190 | 209 | 9 | GO:0042383 |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 2.03e-04 | 12 | 209 | 3 | GO:1990454 | |
| GeneOntologyCellularComponent | cytoplasmic region | TRAF3IP1 CENPF LRRK2 CFAP54 DLG2 DLG4 DNAH6 DYNC1H1 CCDC40 EFCAB6 DNAH2 ABHD13 | 2.87e-04 | 360 | 209 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | transmembrane transporter complex | NDUFA9 RYR3 KCND2 KCNG1 DLG2 DLG4 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 8.26e-04 | 523 | 209 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | caveola | 8.81e-04 | 111 | 209 | 6 | GO:0005901 | |
| GeneOntologyCellularComponent | dendrite | PDGFB ENPP1 LRRK2 BMPR1A KCND2 DLG2 DLG4 CACNA1H PREX1 CACNA1B CACNA1C CACNA1D CACNA1S KIF21A ROR2 GRIN2A SLC9A5 ABHD13 EPHA8 | 1.03e-03 | 858 | 209 | 19 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | PDGFB ENPP1 LRRK2 BMPR1A KCND2 DLG2 DLG4 CACNA1H PREX1 CACNA1B CACNA1C CACNA1D CACNA1S KIF21A ROR2 GRIN2A SLC9A5 ABHD13 EPHA8 | 1.06e-03 | 860 | 209 | 19 | GO:0097447 |
| Domain | VDCCAlpha1 | 2.17e-12 | 10 | 207 | 7 | IPR002077 | |
| Domain | Ca_chan_IQ | 3.29e-09 | 7 | 207 | 5 | SM01062 | |
| Domain | Ca_chan_IQ | 3.29e-09 | 7 | 207 | 5 | PF08763 | |
| Domain | VDCC_a1su_IQ | 3.29e-09 | 7 | 207 | 5 | IPR014873 | |
| Domain | GPHH | 3.29e-09 | 7 | 207 | 5 | PF16905 | |
| Domain | GPHH_dom | 3.29e-09 | 7 | 207 | 5 | IPR031649 | |
| Domain | Channel_four-helix_dom | KCND2 KCNG1 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 1.20e-08 | 57 | 207 | 9 | IPR027359 |
| Domain | - | KCND2 KCNG1 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 1.20e-08 | 57 | 207 | 9 | 1.20.120.350 |
| Domain | VDCC_L_a1su | 1.47e-08 | 4 | 207 | 4 | IPR005446 | |
| Domain | Ion_trans_dom | RYR3 KCND2 KCNG1 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 5.62e-07 | 114 | 207 | 10 | IPR005821 |
| Domain | Ion_trans | RYR3 KCND2 KCNG1 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 5.62e-07 | 114 | 207 | 10 | PF00520 |
| Domain | CAC1F_C | 1.34e-06 | 3 | 207 | 3 | IPR031688 | |
| Domain | CAC1F_C | 1.34e-06 | 3 | 207 | 3 | PF16885 | |
| Domain | PIN_dom | 2.62e-05 | 6 | 207 | 3 | IPR002716 | |
| Domain | PINc | 2.62e-05 | 6 | 207 | 3 | SM00670 | |
| Domain | HISTONE_H3_1 | 4.54e-05 | 7 | 207 | 3 | PS00322 | |
| Domain | RPEL | 4.54e-05 | 7 | 207 | 3 | PS51073 | |
| Domain | RPEL | 4.54e-05 | 7 | 207 | 3 | SM00707 | |
| Domain | RPEL | 4.54e-05 | 7 | 207 | 3 | PF02755 | |
| Domain | RPEL_repeat | 4.54e-05 | 7 | 207 | 3 | IPR004018 | |
| Domain | HISTONE_H3_2 | 7.21e-05 | 8 | 207 | 3 | PS00959 | |
| Domain | Histone_H3/CENP-A | 7.21e-05 | 8 | 207 | 3 | IPR000164 | |
| Domain | H3 | 7.21e-05 | 8 | 207 | 3 | SM00428 | |
| Domain | Pkinase_C | 9.71e-05 | 42 | 207 | 5 | PF00433 | |
| Domain | CCDC74 | 1.22e-04 | 2 | 207 | 2 | IPR033226 | |
| Domain | NMT_1 | 1.22e-04 | 2 | 207 | 2 | PS00975 | |
| Domain | NMT_2 | 1.22e-04 | 2 | 207 | 2 | PS00976 | |
| Domain | CCDC74_C | 1.22e-04 | 2 | 207 | 2 | IPR029422 | |
| Domain | NMT_C | 1.22e-04 | 2 | 207 | 2 | PF02799 | |
| Domain | NMT | 1.22e-04 | 2 | 207 | 2 | PF01233 | |
| Domain | SPS/SelD | 1.22e-04 | 2 | 207 | 2 | IPR004536 | |
| Domain | CCDC74_C | 1.22e-04 | 2 | 207 | 2 | PF14917 | |
| Domain | MyristoylCoA_TrFase_C | 1.22e-04 | 2 | 207 | 2 | IPR022677 | |
| Domain | MyristoylCoA_TrFase_N | 1.22e-04 | 2 | 207 | 2 | IPR022676 | |
| Domain | MyristoylCoA_TrFase_CS | 1.22e-04 | 2 | 207 | 2 | IPR022678 | |
| Domain | MyristoylCoA_TrFase | 1.22e-04 | 2 | 207 | 2 | IPR000903 | |
| Domain | P-loop_NTPase | MYO1G MYO7A SMC1A LRRK2 ZRANB3 ABCB4 DLG2 DLG4 KIFC3 HS3ST4 HS3ST2 DNAH6 DYNC1H1 MPP7 KIF21A DNAH2 DNM1L ARHGAP5 EEF2 GTPBP2 CHTF18 ABCB11 | 1.91e-04 | 848 | 207 | 22 | IPR027417 |
| Domain | PDZ | 2.49e-04 | 148 | 207 | 8 | SM00228 | |
| Domain | - | 2.73e-04 | 150 | 207 | 8 | 2.30.42.10 | |
| Domain | PDZ | 2.85e-04 | 151 | 207 | 8 | PS50106 | |
| Domain | PDZ | 2.98e-04 | 152 | 207 | 8 | IPR001478 | |
| Domain | VDCC_T_a1 | 3.64e-04 | 3 | 207 | 2 | IPR005445 | |
| Domain | - | 3.64e-04 | 3 | 207 | 2 | 3.90.650.10 | |
| Domain | AGC-kinase_C | 3.85e-04 | 56 | 207 | 5 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.85e-04 | 56 | 207 | 5 | PS51285 | |
| Domain | S_TK_X | 3.85e-04 | 56 | 207 | 5 | SM00133 | |
| Domain | ARM-type_fold | LRRK2 MROH5 ARID1A RYR3 UNC79 PPP4R1 USP24 PPP4R4 IPO9 UPF2 FHOD1 SYMPK | 4.18e-04 | 339 | 207 | 12 | IPR016024 |
| Domain | Dynein_heavy_chain_D4_dom | 4.46e-04 | 14 | 207 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.46e-04 | 14 | 207 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.46e-04 | 14 | 207 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.46e-04 | 14 | 207 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.46e-04 | 14 | 207 | 3 | IPR011704 | |
| Domain | MT | 4.46e-04 | 14 | 207 | 3 | PF12777 | |
| Domain | AAA_8 | 4.46e-04 | 14 | 207 | 3 | PF12780 | |
| Domain | AAA_5 | 4.46e-04 | 14 | 207 | 3 | PF07728 | |
| Domain | DHC_fam | 5.53e-04 | 15 | 207 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 5.53e-04 | 15 | 207 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.53e-04 | 15 | 207 | 3 | IPR004273 | |
| Domain | - | MYO7A SMC1A LRRK2 ZRANB3 ABCB4 DLG2 DLG4 HS3ST4 HS3ST2 DNAH6 DYNC1H1 MPP7 DNAH2 DNM1L ARHGAP5 EEF2 GTPBP2 CHTF18 ABCB11 | 6.62e-04 | 746 | 207 | 19 | 3.40.50.300 |
| Domain | Guanylate_kinase_CS | 6.75e-04 | 16 | 207 | 3 | IPR020590 | |
| Domain | MAGUK_N_PEST | 7.23e-04 | 4 | 207 | 2 | PF10608 | |
| Domain | PDZ_assoc | 7.23e-04 | 4 | 207 | 2 | PF10600 | |
| Domain | WRNPLPNID | 7.23e-04 | 4 | 207 | 2 | IPR033461 | |
| Domain | DLG1_PEST_dom | 7.23e-04 | 4 | 207 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 7.23e-04 | 4 | 207 | 2 | IPR019583 | |
| Domain | MAGUK_N_PEST | 7.23e-04 | 4 | 207 | 2 | SM01277 | |
| Domain | DLG1 | 7.23e-04 | 4 | 207 | 2 | IPR016313 | |
| Domain | - | 7.23e-04 | 4 | 207 | 2 | 3.30.1330.10 | |
| Domain | WRNPLPNID | 7.23e-04 | 4 | 207 | 2 | PF15017 | |
| Domain | AIRS_C | 7.23e-04 | 4 | 207 | 2 | PF02769 | |
| Domain | PIN_4 | 7.23e-04 | 4 | 207 | 2 | PF13638 | |
| Domain | AIRS | 7.23e-04 | 4 | 207 | 2 | PF00586 | |
| Domain | PurM-like_N | 7.23e-04 | 4 | 207 | 2 | IPR016188 | |
| Domain | AIR_synth_C_dom | 7.23e-04 | 4 | 207 | 2 | IPR010918 | |
| Domain | PDZ | 1.00e-03 | 141 | 207 | 7 | PF00595 | |
| Domain | KIND_dom | 1.20e-03 | 5 | 207 | 2 | IPR011019 | |
| Domain | KIND | 1.20e-03 | 5 | 207 | 2 | SM00750 | |
| Domain | KIND | 1.20e-03 | 5 | 207 | 2 | PS51377 | |
| Domain | Znf_FYVE_PHD | 1.28e-03 | 147 | 207 | 7 | IPR011011 | |
| Domain | PHD | 1.47e-03 | 75 | 207 | 5 | PF00628 | |
| Domain | - | CBLL1 KDM5B SPIRE2 PHF20 KMT2A DNMT3L PDZRN4 RC3H2 PHF12 BAZ1B TRIM10 SYVN1 RFPL3 | 1.56e-03 | 449 | 207 | 13 | 3.30.40.10 |
| Domain | DNA/RNA_non-sp_Endonuclease | 1.78e-03 | 6 | 207 | 2 | IPR001604 | |
| Domain | - | 1.78e-03 | 6 | 207 | 2 | 3.40.570.10 | |
| Domain | Endonuclease_NS | 1.78e-03 | 6 | 207 | 2 | PF01223 | |
| Domain | Extracellular_endonuc_su_A | 1.78e-03 | 6 | 207 | 2 | IPR020821 | |
| Domain | NUC | 1.78e-03 | 6 | 207 | 2 | SM00477 | |
| Domain | Endonuclease_NS | 1.78e-03 | 6 | 207 | 2 | SM00892 | |
| Domain | Znf_PHD-finger | 1.85e-03 | 79 | 207 | 5 | IPR019787 | |
| Domain | PROTEIN_KINASE_ATP | RPS6KA1 LRRK2 BMPR1A TAOK3 NRK DMPK PIM2 ROR2 CDK13 PRKCI PKN1 MAST3 EPHA8 | 1.89e-03 | 459 | 207 | 13 | PS00107 |
| Domain | Znf_RING/FYVE/PHD | CBLL1 KDM5B SPIRE2 PHF20 KMT2A DNMT3L PDZRN4 RC3H2 PHF12 BAZ1B TRIM10 SYVN1 RFPL3 | 1.89e-03 | 459 | 207 | 13 | IPR013083 |
| Domain | GUANYLATE_KINASE_2 | 2.02e-03 | 23 | 207 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 2.02e-03 | 23 | 207 | 3 | PS00856 | |
| Domain | Ser/Thr_kinase_AS | RPS6KA1 LRRK2 BMPR1A TAOK3 NRK DMPK PIM2 CDK13 PRKCI PKN1 MAST3 | 2.19e-03 | 357 | 207 | 11 | IPR008271 |
| Domain | S_TKc | RPS6KA1 LRRK2 BMPR1A TAOK3 NRK DMPK PIM2 CDK13 PRKCI PKN1 MAST3 | 2.29e-03 | 359 | 207 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_ST | RPS6KA1 LRRK2 BMPR1A TAOK3 NRK DMPK PIM2 CDK13 PRKCI PKN1 MAST3 | 2.44e-03 | 362 | 207 | 11 | PS00108 |
| Domain | Guanylate_kin | 2.89e-03 | 26 | 207 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 2.89e-03 | 26 | 207 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 2.89e-03 | 26 | 207 | 3 | IPR008144 | |
| Domain | GuKc | 2.89e-03 | 26 | 207 | 3 | SM00072 | |
| Domain | Kinase-like_dom | RPS6KA1 LRRK2 BMPR1A TAOK3 PTPN13 NRK DMPK PIM2 ROR2 CDK13 PRKCI PKN1 MAST3 EPHA8 | 2.97e-03 | 542 | 207 | 14 | IPR011009 |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.31e-09 | 6 | 167 | 5 | M47762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 6.03e-09 | 23 | 167 | 7 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.16e-08 | 25 | 167 | 7 | M47948 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 5.88e-06 | 11 | 167 | 4 | M47958 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 9.31e-06 | 42 | 167 | 6 | M7169 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 1.73e-05 | 14 | 167 | 4 | M47692 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGH_MMSET_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 6.41e-05 | 19 | 167 | 4 | M47442 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.82e-05 | 63 | 167 | 6 | M11187 | |
| Pathway | WP_MAPK_SIGNALING | PDGFB LRRK2 TAOK3 CACNA1I CACNA1H FGF14 CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 1.68e-04 | 246 | 167 | 11 | M39597 |
| Pathway | WP_ALZHEIMERS_DISEASE | 2.41e-04 | 74 | 167 | 6 | MM15962 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 2.70e-04 | 178 | 167 | 9 | M2890 |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | PDGFB RPS6KA1 TAOK3 CACNA1I CACNA1H FGF14 CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 3.41e-04 | 267 | 167 | 11 | M10792 |
| Pubmed | 1.40e-12 | 8 | 214 | 6 | 28330839 | ||
| Pubmed | 4.18e-12 | 9 | 214 | 6 | 16382099 | ||
| Pubmed | 1.75e-10 | 7 | 214 | 5 | 12900400 | ||
| Pubmed | 1.39e-09 | 4 | 214 | 4 | 20937870 | ||
| Pubmed | 3.77e-09 | 11 | 214 | 5 | 15471871 | ||
| Pubmed | PHACTR2 CENPF MRPS35 ARID1A H3C15 ABCB4 BMPR1A H3C1 KMT2A DLG2 DNAH6 CCDC191 PREX1 CACNA1C H3-5 HYOU1 KIF21A DNAH2 RCN1 CCDC57 PPP4R4 SEPHS2 SEPHS1 EEF2 KIAA0825 CDK13 ARHGAP12 FAM169A H3-3A SPEN | 5.84e-09 | 1442 | 214 | 30 | 35575683 | |
| Pubmed | KDM5B TRAF3IP1 SMC1A ZBTB43 MRPS35 ZNF202 DARS1 ARID1A MOAP1 GFPT1 RYR3 PTPN13 OTOF NMT2 DLG2 DLG4 KIFC3 PREX1 DYNC1H1 PPP4R1 KIF21A OBSL1 ACOT1 ARHGAP5 EEF2 PNMA2 H3-3A ANKRD36 | 7.38e-09 | 1285 | 214 | 28 | 35914814 | |
| Pubmed | 2.40e-08 | 15 | 214 | 5 | 20188150 | ||
| Pubmed | 2.40e-08 | 15 | 214 | 5 | 24453333 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.19e-07 | 38 | 214 | 6 | 30786075 | |
| Pubmed | ENPP1 RPS6KA1 TAOK3 KMT2A DENND5A NMT1 PPP4R1 RC3H2 HYOU1 POLRMT OBSL1 DIS3 GTPBP2 UPF2 CDK13 AP5B1 CHTF18 PRKCI | 1.36e-07 | 650 | 214 | 18 | 38777146 | |
| Pubmed | CENPF ARID1A GFPT1 PNPT1 KMT2A CLUH DYNC1H1 HYOU1 POLA1 USP24 POLRMT NOL11 BAZ1B DIS3 GTF2I SPEN RPL7 SYMPK | 1.46e-07 | 653 | 214 | 18 | 22586326 | |
| Pubmed | USP18 PSG6 RPS6KA1 ARID1A GFPT1 BMPR1A UBE2N KCNG1 KMT2A DMPK RC3H2 USP24 DNAH2 DNM1L SEPHS2 SEPHS1 CDK13 CORO6 PRKCI | 1.57e-07 | 730 | 214 | 19 | 34857952 | |
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 17767505 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 2173707 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 17289261 | ||
| Pubmed | A developmental change in NMDA receptor-associated proteins at hippocampal synapses. | 2.30e-07 | 3 | 214 | 3 | 10648730 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPIRE2 MYO7A ARID1A KCNG1 CACNA1H KIFC3 DENND5A DOCK6 PREX1 DYNC1H1 RASAL1 SMG6 PHF12 NOB1 POLRMT SEPHS2 PWWP2B POMGNT2 CDK13 PKN1 SYVN1 SPEN SYMPK | 3.99e-07 | 1105 | 214 | 23 | 35748872 |
| Pubmed | 4.45e-07 | 11 | 214 | 4 | 18809727 | ||
| Pubmed | MYO7A MRPS35 NDUFA9 ARID1A GFPT1 UBE2N C5 PREX1 PHF12 NOB1 USP24 DNAH2 PPP4R4 IPO9 PRELP PHACTR3 SPEN | 5.24e-07 | 638 | 214 | 17 | 31182584 | |
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 28452394 | ||
| Pubmed | USP38 Couples Histone Ubiquitination and Methylation via KDM5B to Resolve Inflammation. | 9.15e-07 | 4 | 214 | 3 | 33240782 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CBLL1 CENPF SMC1A MRPS35 DARS1 ARHGAP11A NDUFA9 GFPT1 H3C1 NMT1 DYNC1H1 HYOU1 NOB1 POLRMT NOL11 BAZ1B IFI16 LRCH3 EEF2 GTF2I UPF2 FHOD1 SPEN RPL7 | 1.02e-06 | 1257 | 214 | 24 | 36526897 |
| Pubmed | SMC1A DARS1 GFPT1 KMT2A NMT1 DYNC1H1 RCN1 POLRMT BAZ1B DNM1L IFI16 DIS3 LRCH3 EEF2 IPO9 RPL7 | 1.16e-06 | 601 | 214 | 16 | 33658012 | |
| Pubmed | 1.33e-06 | 14 | 214 | 4 | 16267050 | ||
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 7309716 | ||
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 11296258 | ||
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 16185088 | ||
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 15451373 | ||
| Pubmed | 2.98e-06 | 142 | 214 | 8 | 30809309 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SMC1A DARS1 NDUFA9 ARID1A GFPT1 DYNC1H1 POLA1 KIF21A NOB1 POLRMT NOL11 BAZ1B IFI16 H3-7 DIS3 AARSD1 EEF2 IPO9 GTF2I TFB1M UPF2 CHTF18 FHOD1 RPL7 | 3.61e-06 | 1353 | 214 | 24 | 29467282 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYO7A CENPF ARHGAP11A H3C15 GFPT1 UBE2N KCNG1 DYNC1H1 CACNA1F CYP26B1 YBEY POLA1 KIF21A DNAH2 ARHGAP5 RPL7 SYMPK | 3.61e-06 | 736 | 214 | 17 | 29676528 |
| Pubmed | 3.64e-06 | 103 | 214 | 7 | 32744500 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | SMC1A RPS6KA1 DARS1 GFPT1 NMT1 PLOD2 CLUH DYNC1H1 RASAL1 PPP4R1 CACNA1S HYOU1 POLA1 KIF21A USP24 RCN1 DNM1L DIS3 AARSD1 EEF2 IPO9 GTF2I ASL PNMA2 H3-3A | 3.89e-06 | 1455 | 214 | 25 | 22863883 |
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 4.53e-06 | 6 | 214 | 3 | 16029198 | |
| Pubmed | 4.53e-06 | 6 | 214 | 3 | 10464286 | ||
| Pubmed | Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. | 4.53e-06 | 6 | 214 | 3 | 15525939 | |
| Pubmed | Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase. | 4.53e-06 | 6 | 214 | 3 | 12560483 | |
| Pubmed | Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification. | 4.53e-06 | 6 | 214 | 3 | 17189264 | |
| Pubmed | Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. | 4.53e-06 | 6 | 214 | 3 | 20228790 | |
| Pubmed | Organismal differences in post-translational modifications in histones H3 and H4. | 4.53e-06 | 6 | 214 | 3 | 17194708 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SMC1A KMT2A NMT1 CLUH PHF12 USP24 BAZ1B IFI16 EEF2 PWWP2B GTF2I CDK13 CHTF18 FHOD1 PKN1 SPEN SYMPK | 6.98e-06 | 774 | 214 | 17 | 15302935 |
| Pubmed | SMC1A DARS1 UBE2N STOML3 DYNC1H1 HYOU1 POLA1 NOB1 AARSD1 EEF2 IPO9 UPF2 CHTF18 RPL7 | 7.10e-06 | 538 | 214 | 14 | 28524877 | |
| Pubmed | Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. | 7.68e-06 | 21 | 214 | 4 | 11242053 | |
| Pubmed | Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins. | 7.90e-06 | 7 | 214 | 3 | 15107502 | |
| Pubmed | 7.90e-06 | 7 | 214 | 3 | 15684425 | ||
| Pubmed | Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. | 7.90e-06 | 7 | 214 | 3 | 11856369 | |
| Pubmed | 7.90e-06 | 7 | 214 | 3 | 15681610 | ||
| Pubmed | 7.90e-06 | 7 | 214 | 3 | 19243221 | ||
| Pubmed | 7.90e-06 | 7 | 214 | 3 | 16497732 | ||
| Pubmed | Different expression patterns of Phactr family members in normal and injured mouse brain. | 7.90e-06 | 7 | 214 | 3 | 22766235 | |
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 9.67e-06 | 79 | 214 | 6 | 26446488 | |
| Pubmed | SMC1A DARS1 UBE2N DYNC1H1 HYOU1 POLA1 USP24 NOL11 DNM1L DIS3 EEF2 IPO9 GTF2I RPL7 SYMPK | 1.11e-05 | 638 | 214 | 15 | 33239621 | |
| Pubmed | 1.26e-05 | 8 | 214 | 3 | 26609151 | ||
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 1.26e-05 | 8 | 214 | 3 | 12761855 | |
| Pubmed | DARS1 ALKBH5 GFPT1 PNPT1 UBE2N KMT2A C5 NMT1 PLOD2 DYNC1H1 MEAF6 RC3H2 OBSL1 NOL11 ARHGAP5 EEF2 IPO9 GTF2I TFB1M UPF2 CDK13 PRKCI RPL7 | 1.42e-05 | 1371 | 214 | 23 | 36244648 | |
| Pubmed | MRPS35 SCD5 NDUFA9 PNPT1 PTPN13 H3C1 UBE2N PLOD2 CLUH MPP7 HYOU1 DNAJC25 ROR2 RCN1 POLRMT OBSL1 NOL11 BAZ1B ACOT1 PDHX PRKCI REEP4 RPL7 MAST3 | 1.72e-05 | 1487 | 214 | 24 | 33957083 | |
| Pubmed | Crystal structure of DPF3b in complex with an acetylated histone peptide. | 1.88e-05 | 9 | 214 | 3 | 27402533 | |
| Pubmed | 1.88e-05 | 9 | 214 | 3 | 9278515 | ||
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 2.15e-05 | 186 | 214 | 8 | 33637726 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYO7A SMC1A ARID1A H3C1 DNAH6 DYNC1H1 KIF21A DNAH2 RCN1 DNM1L SEPHS2 SEPHS1 IPO9 GTF2I UPF2 H3-3A RPL7 | 2.21e-05 | 847 | 214 | 17 | 35235311 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SMC1A MRPS35 DARS1 NDUFA9 GFPT1 PNPT1 UBE2N NMT1 CLUH DYNC1H1 HYOU1 POLA1 KIF21A NOB1 USP24 RCN1 DIS3 EEF2 GTF2I CDK13 CHTF18 FHOD1 RPL7 | 2.34e-05 | 1415 | 214 | 23 | 28515276 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SMC1A MRPS35 DARS1 NDUFA9 TAOK3 H3C1 UBE2N KMT2A DYNC1H1 HYOU1 NOB1 USP24 NOL11 BAZ1B DNM1L DIS3 EEF2 IPO9 GTF2I UPF2 H3-3A RPL7 | 2.38e-05 | 1318 | 214 | 22 | 30463901 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ENDOD1 TRAF3IP1 MYO7A SMC1A MRPS35 NDUFA9 PTPN13 PANK2 UBE2N NMT1 CLUH DYNC1H1 CCDC40 OBSL1 DIS3 LRCH3 IPO9 GTF2I H3-3A PRKCI REEP4 MAST3 | 2.47e-05 | 1321 | 214 | 22 | 27173435 |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.60e-05 | 139 | 214 | 7 | 16985003 | |
| Pubmed | CBLL1 ENDOD1 RPP21 GFPT1 KMT2A MEAF6 PPP4R1 MRM2 YBEY POLA1 PHF12 DNM1L PPP4R4 GTPBP2 IPO9 GTF2I TRMT44 UPF2 CDK13 FAM169A REEP4 SYVN1 | 2.64e-05 | 1327 | 214 | 22 | 32694731 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | SMC1A MAP1LC3A DARS1 H3C15 GFPT1 H3C1 DYNC1H1 H3-5 NOB1 OBSL1 IFI16 H3-7 LRCH3 EEF2 GTF2I TFB1M CDK13 RPL7 | 2.66e-05 | 949 | 214 | 18 | 36574265 |
| Pubmed | 2.67e-05 | 10 | 214 | 3 | 24778262 | ||
| Pubmed | MYO7A DARS1 NDUFA9 ARID1A MGAT3 PLPPR4 NMT2 KMT2A DLG2 DLG4 DNAH6 DYNC1H1 RASAL1 HYOU1 DNM1L GRIN2A PDHX LRCH3 ARHGAP5 EEF2 UPF2 CORO6 RPL7 | 2.78e-05 | 1431 | 214 | 23 | 37142655 | |
| Pubmed | CBLL1 TRAF3IP1 CENPF PLPPR4 UBE2N DLG2 DLG4 UNC79 DYNC1H1 RASAL1 SMG6 KIF21A DNM1L GRIN2A EEF2 PRKCI PKN1 PHACTR1 | 3.22e-05 | 963 | 214 | 18 | 28671696 | |
| Pubmed | Ephrin-A5 and EphA5 interaction induces synaptogenesis during early hippocampal development. | 3.65e-05 | 11 | 214 | 3 | 20824214 | |
| Pubmed | Human PAD4 regulates histone arginine methylation levels via demethylimination. | 3.65e-05 | 11 | 214 | 3 | 15345777 | |
| Pubmed | 3.65e-05 | 11 | 214 | 3 | 23319141 | ||
| Pubmed | Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice. | 3.77e-05 | 2 | 214 | 2 | 30416103 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 25277766 | ||
| Pubmed | Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. | 3.77e-05 | 2 | 214 | 2 | 12244217 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 31886153 | ||
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 3.77e-05 | 2 | 214 | 2 | 12808460 | |
| Pubmed | An opposing function of paralogs in balancing developmental synapse maturation. | 3.77e-05 | 2 | 214 | 2 | 30586380 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 35691019 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 25071191 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 1281468 | ||
| Pubmed | Hypersocial behavior and biological redundancy in mice with reduced expression of PSD95 or PSD93. | 3.77e-05 | 2 | 214 | 2 | 28189758 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 35979628 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 9971769 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 21054386 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 26735860 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 29138442 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 2692561 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 36786913 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 24787897 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 36193086 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 16890614 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 32164788 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 2737204 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 3.77e-05 | 2 | 214 | 2 | 25966695 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 19403686 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 23184449 | ||
| Pubmed | Entropic switch regulates myristate exposure in the HIV-1 matrix protein. | 3.77e-05 | 2 | 214 | 2 | 14699046 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 24086669 | ||
| Interaction | TOP3B interactions | SPIRE2 MYO7A CENPF SMC1A DARS1 ARID1A H3C1 KCNG1 CACNA1H KIFC3 DENND5A DOCK6 NMT1 PREX1 DYNC1H1 RASAL1 SMG6 RC3H2 HYOU1 PHF12 NOB1 RCN1 POLRMT SEPHS2 PWWP2B GTF2I POMGNT2 UPF2 CDK13 PNMA2 H3-3A PKN1 SYVN1 SPEN SYMPK | 4.93e-06 | 1470 | 213 | 35 | int:TOP3B |
| Interaction | SCN5A interactions | 9.72e-06 | 47 | 213 | 6 | int:SCN5A | |
| Interaction | DSCAM interactions | ZBTB43 ZNF202 GFPT1 PTPN13 DLG2 DLG4 KIFC3 DYNC1H1 KIF21A EEF2 | 1.45e-05 | 171 | 213 | 10 | int:DSCAM |
| Interaction | H2BC9 interactions | PHACTR2 TRAF3IP1 ENPP1 SMC1A H3C15 H3C1 OTOF DNAH6 H3-5 BAZ1B H3-7 IPO9 ZFHX4 H3-3A ANKRD36 PHACTR1 | 2.27e-05 | 446 | 213 | 16 | int:H2BC9 |
| GeneFamily | Calcium voltage-gated channel subunits | 1.42e-09 | 26 | 151 | 7 | 253 | |
| GeneFamily | Phosphatase and actin regulators | 2.27e-06 | 4 | 151 | 3 | 679 | |
| GeneFamily | PDZ domain containing | 4.18e-05 | 152 | 151 | 8 | 1220 | |
| GeneFamily | Protein phosphatase 4 regulatory subunits | 2.07e-04 | 3 | 151 | 2 | 698 | |
| GeneFamily | PHD finger proteins | 9.45e-04 | 90 | 151 | 5 | 88 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.29e-03 | 26 | 151 | 3 | 904 | |
| GeneFamily | Histones | 2.90e-03 | 116 | 151 | 5 | 864 | |
| GeneFamily | ATP binding cassette subfamily B | 3.63e-03 | 11 | 151 | 2 | 806 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 3.63e-03 | 11 | 151 | 2 | 1315 | |
| GeneFamily | Paraneoplastic Ma antigens | 3.63e-03 | 11 | 151 | 2 | 671 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | GARIN1A SCD5 TAOK3 PLPPR4 KCND2 HS3ST4 UNC79 PDZRN4 CACNA1B CACNA1C KIF21A ZFHX4 PHACTR3 PNMA2 FAM169A ZFHX3 CHSY3 | 6.46e-06 | 584 | 213 | 17 | M39068 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | PHF20 SHROOM4 DLG2 KIFC3 CCDC191 SMG6 CACNA1C CACNA1D TENT5A DNAH2 BAZ1B PDHX UPF2 EPHA8 | 8.93e-06 | 417 | 213 | 14 | M39224 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CBLL1 PHF20 TRAF3IP1 SMC1A ARID1A ZRANB3 USP38 DYNC1H1 MPP7 MEAF6 CACNA1F PHF12 KIF21A USP24 BAZ1B DNM1L XPNPEP2 ARHGAP5 SEPHS1 UPF2 | 2.38e-06 | 595 | 212 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CBLL1 TRAF3IP1 CENPF SMC1A ARID1A ZRANB3 USP38 MPP7 PHF12 KIF21A USP24 DNAH2 BAZ1B DNM1L XPNPEP2 ARHGAP5 CLIP3 SEPHS1 UPF2 FAM169A | 5.47e-06 | 629 | 212 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | SLC44A5 PLPPR4 KCND2 FGF14 UNC79 CACNA1B CACNA1C CACNA1D GRIN2A GALNT17 CHSY3 ANKRD36 PHACTR1 | 1.58e-11 | 198 | 214 | 13 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PLPPR4 FGF14 UNC79 CACNA1B CACNA1C CACNA1D GRIN2A GALNT17 CORO6 CHSY3 ANKRD36 PHACTR1 | 2.17e-10 | 196 | 214 | 12 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | PLPPR4 FGF14 UNC79 CACNA1B CACNA1C CACNA1D GRIN2A GALNT17 CORO6 CHSY3 ANKRD36 PHACTR1 | 2.75e-10 | 200 | 214 | 12 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PLPPR4 KCND2 FGF14 UNC79 CACNA1B CACNA1C CACNA1D GRIN2A GALNT17 CORO6 CHSY3 | 3.47e-09 | 198 | 214 | 11 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PLPPR4 FGF14 UNC79 CACNA1B CACNA1C CACNA1D GRIN2A GALNT17 CORO6 CHSY3 ANKRD36 | 3.47e-09 | 198 | 214 | 11 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ENPP1 CFAP54 NRK GYG2 PLOD2 PDZRN4 ROR2 OBSL1 PPP4R4 PRELP PHACTR3 | 3.85e-09 | 200 | 214 | 11 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ENPP1 CFAP54 NRK GYG2 PLOD2 PDZRN4 ROR2 OBSL1 PPP4R4 PRELP PHACTR3 | 3.85e-09 | 200 | 214 | 11 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | FGF14 DOCK6 CACNA1C COL6A3 CYP26B1 ROR2 GALNT17 HMCN1 PRELP CORO6 | 8.86e-09 | 167 | 214 | 10 | d584a8548a5317bd9686b3be8246ae6ed568796b |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | RYR3 TBATA PLPPR4 KCNG1 CACNA1H HS3ST4 RASAL1 GRIN2A GALNT17 MAST3 | 9.38e-09 | 168 | 214 | 10 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | USP18 TRAF3IP1 ANKRD36C ABCB4 KIFC3 OBSL1 AARSD1 ARHGAP5 ANKRD36 SYVN1 | 2.60e-08 | 187 | 214 | 10 | a3592f056e1c2f82ba325fea2ecc4dd6c6347c81 |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.44e-08 | 144 | 214 | 9 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | KCND2 FGF14 UNC79 CACNA1B CACNA1C CACNA1D GRIN2A GALNT17 CORO6 PHACTR1 | 4.47e-08 | 198 | 214 | 10 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-07 | 175 | 214 | 9 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | SCARF2 CACNA1C CACNA1D COL6A3 ROR2 GALNT17 HMCN1 FHOD1 PHACTR3 | 3.21e-07 | 187 | 214 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-07 | 191 | 214 | 9 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | PHACTR2 DLG2 FGF14 KIFC3 CACNA1D COL6A3 GALNT17 HMCN1 PHACTR3 | 4.01e-07 | 192 | 214 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | DLG2 FGF14 CACNA1C CACNA1D COL6A3 ROR2 GALNT17 HMCN1 PHACTR3 | 4.57e-07 | 195 | 214 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.19e-07 | 198 | 214 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FGF14 HS3ST2 CACNA1C CACNA1D COL6A3 ROR2 HMCN1 PRELP PHACTR3 | 5.65e-07 | 200 | 214 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-06 | 176 | 214 | 8 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-06 | 177 | 214 | 8 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-06 | 180 | 214 | 8 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-06 | 127 | 214 | 7 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-06 | 128 | 214 | 7 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 184 | 214 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 184 | 214 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 184 | 214 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 184 | 214 | 8 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.40e-06 | 186 | 214 | 8 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 186 | 214 | 8 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 186 | 214 | 8 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 3.53e-06 | 187 | 214 | 8 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.53e-06 | 187 | 214 | 8 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 3.53e-06 | 187 | 214 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.53e-06 | 187 | 214 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 3.68e-06 | 188 | 214 | 8 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.97e-06 | 190 | 214 | 8 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.13e-06 | 191 | 214 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.29e-06 | 192 | 214 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.46e-06 | 193 | 214 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.46e-06 | 193 | 214 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.46e-06 | 193 | 214 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.46e-06 | 193 | 214 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.81e-06 | 195 | 214 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.81e-06 | 195 | 214 | 8 | 30ed961151b8b1f6ce37f06c9a061519f01c2864 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 4.81e-06 | 195 | 214 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 195 | 214 | 8 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-06 | 196 | 214 | 8 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.00e-06 | 196 | 214 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-06 | 197 | 214 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.19e-06 | 197 | 214 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.38e-06 | 198 | 214 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.38e-06 | 198 | 214 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.38e-06 | 198 | 214 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.38e-06 | 198 | 214 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 5.38e-06 | 198 | 214 | 8 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.59e-06 | 199 | 214 | 8 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | 7cea58e2691564e653cc972bf5aaff2df1f2666e | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | 193c42c31a366a60d80c4c1fc6a1592a5b01a3ad | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)---|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | 7c780e995a5fc3793080da61b6bf7a12880e9df8 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)----L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | d0b31dc5eedc0635c0d7ceabaa6202386cf2a4a4 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | 8444ae3c10b1152dec67ca812e6c417cc3b9cf89 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | 1ce9599cc9d8158e8842ca56f35fa7809c234849 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | 7b845aabfbdfe893acc9334a5707833761bed60b | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | 0638273fc0910f47fe7a0b6d9a8639b0e9976d13 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.11e-05 | 157 | 214 | 7 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.16e-05 | 158 | 214 | 7 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.21e-05 | 159 | 214 | 7 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-05 | 162 | 214 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 165 | 214 | 7 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 165 | 214 | 7 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-05 | 169 | 214 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.86e-05 | 170 | 214 | 7 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-05 | 172 | 214 | 7 | 1cfea985c5959b38beea351b892cd5e92e27f927 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 174 | 214 | 7 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-05 | 176 | 214 | 7 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.41e-05 | 177 | 214 | 7 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.50e-05 | 178 | 214 | 7 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-05 | 179 | 214 | 7 | c815eb9f760fe4ca7a5e49beb224659f0b864f22 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.59e-05 | 179 | 214 | 7 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-05 | 179 | 214 | 7 | b35a7f8115c997c390201da01d7cb10b10769aec | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 180 | 214 | 7 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-05 | 180 | 214 | 7 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-05 | 180 | 214 | 7 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 180 | 214 | 7 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.79e-05 | 181 | 214 | 7 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-05 | 182 | 214 | 7 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 183 | 214 | 7 | b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.09e-05 | 184 | 214 | 7 | 235890e8b424f4386b6ea52d173d20a00898df73 | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.20e-05 | 185 | 214 | 7 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 185 | 214 | 7 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 186 | 214 | 7 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 186 | 214 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| Drug | Cinnarizine | 5.27e-11 | 9 | 214 | 6 | DB00568 | |
| Drug | Mibefradil | 2.86e-10 | 11 | 214 | 6 | DB01388 | |
| Drug | CNS 1145 | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 6.06e-10 | 33 | 214 | 8 | CID000190902 |
| Drug | IHC-64 | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 6.06e-10 | 33 | 214 | 8 | CID000162753 |
| Drug | Verapamil | 4.76e-09 | 16 | 214 | 6 | DB00661 | |
| Drug | IAA-94 | ENPP1 RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 5.49e-09 | 61 | 214 | 9 | CID000003667 |
| Drug | Cinildipine | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 5.15e-08 | 56 | 214 | 8 | CID000002752 |
| Drug | loperamide | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A PRKCI | 5.78e-08 | 105 | 214 | 10 | CID000003954 |
| Drug | nilvadipine | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 8.99e-08 | 60 | 214 | 8 | CID000004494 |
| Drug | lercanidipine | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 1.33e-07 | 63 | 214 | 8 | CID000065866 |
| Drug | butamben | 1.95e-07 | 15 | 214 | 5 | CID000002482 | |
| Drug | gallopamil | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 2.17e-07 | 67 | 214 | 8 | CID000001234 |
| Drug | Amlodipine | 2.60e-07 | 7 | 214 | 4 | DB00381 | |
| Drug | Isradipine | 2.60e-07 | 7 | 214 | 4 | DB00270 | |
| Drug | AC1L2AC7 | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 2.73e-07 | 69 | 214 | 8 | CID000068733 |
| Drug | manidipine | PDGFB RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 2.83e-07 | 95 | 214 | 9 | CID000004008 |
| Drug | KW-3049 | 4.16e-07 | 50 | 214 | 7 | CID000002324 | |
| Drug | CAS 298-57-7 | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 4.25e-07 | 73 | 214 | 8 | CID000002761 |
| Drug | ethosuximide | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 4.73e-07 | 74 | 214 | 8 | CID000003291 |
| Drug | Nifedipine | 5.16e-07 | 8 | 214 | 4 | DB01115 | |
| Drug | Nitrendipine | 5.16e-07 | 8 | 214 | 4 | DB01054 | |
| Drug | nisoldipine | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 7.13e-07 | 78 | 214 | 8 | CID000004499 |
| Drug | N-cyclopentyl-N-cyclobutylformamide | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 7.86e-07 | 79 | 214 | 8 | CID005287890 |
| Drug | Nimodipine | 9.22e-07 | 9 | 214 | 4 | DB00393 | |
| Drug | Dantrolene-13C3 | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A TECTA | 1.19e-06 | 145 | 214 | 10 | CID000002951 |
| Drug | lamotrigine | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 1.55e-06 | 116 | 214 | 9 | CID000003878 |
| Drug | Bay K 8644 | RYR3 CACNA1I CACNA1H DMPK CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S PRKCI | 1.62e-06 | 150 | 214 | 10 | CID000002303 |
| Drug | AC1NBU2S | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S PIM2 | 1.66e-06 | 117 | 214 | 9 | CID004473765 |
| Drug | mibefradil | 2.32e-06 | 64 | 214 | 7 | CID000060662 | |
| Drug | Felodipine | 2.38e-06 | 11 | 214 | 4 | DB01023 | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | ENDOD1 PHF20 TRAF3IP1 IRF6 ARID1A GYG2 PIM2 BAZ1B SLC9A5 FAM169A MAST3 | 2.65e-06 | 196 | 214 | 11 | 6813_DN |
| Drug | isotetrandrine | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 3.77e-06 | 97 | 214 | 8 | CID000005422 |
| Drug | nitrendipine | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 4.07e-06 | 98 | 214 | 8 | CID000004507 |
| Drug | isradipine | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 4.74e-06 | 100 | 214 | 8 | CID000003784 |
| Drug | gabapentin | GFPT1 RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 4.75e-06 | 169 | 214 | 10 | CID000003446 |
| Drug | felodipine | RYR3 CYP2W1 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S CYP26B1 | 4.75e-06 | 169 | 214 | 10 | CID000003333 |
| Drug | lavendustin A | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A PRKCI | 5.27e-06 | 171 | 214 | 10 | CID000003894 |
| Drug | AC1L1JG6 | 7.06e-06 | 14 | 214 | 4 | CID000005026 | |
| Drug | pyraclofos | 7.32e-06 | 106 | 214 | 8 | CID000093460 | |
| Drug | Nisoldipine | 8.08e-06 | 5 | 214 | 3 | DB00401 | |
| Drug | Nilvadipine | 8.08e-06 | 5 | 214 | 3 | DB06712 | |
| Drug | NSC7524 | RYR3 CACNA1I CACNA1H DMPK CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 9.15e-06 | 182 | 214 | 10 | CID000005657 |
| Drug | FPL 64176 | 9.55e-06 | 15 | 214 | 4 | CID000003423 | |
| Drug | nimodipine | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 9.72e-06 | 145 | 214 | 9 | CID000004497 |
| Drug | nicardipine | SCD5 RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 9.72e-06 | 145 | 214 | 9 | CID000004473 |
| Drug | AC1L1GTQ | 1.14e-05 | 54 | 214 | 6 | CID000003836 | |
| Drug | cyclophorine | PDGFB RYR3 ABCB4 CACNA1I CACNA1H KLK5 CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S COL6A3 USP24 ABCB11 PRKCI | 1.34e-05 | 426 | 214 | 15 | CID000002909 |
| Drug | procaine | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S PRKCI | 1.50e-05 | 153 | 214 | 9 | CID000004914 |
| Drug | dihydropyridine | RYR3 CACNA1I CACNA1H DMPK CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S PRKCI | 1.53e-05 | 193 | 214 | 10 | CID000104822 |
| Drug | CPU-23 | 1.60e-05 | 6 | 214 | 3 | CID003036051 | |
| Drug | 3,4-dihydroquinazoline | 1.60e-05 | 6 | 214 | 3 | CID000583065 | |
| Drug | efonidipine | 1.64e-05 | 17 | 214 | 4 | CID000119170 | |
| Drug | Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.90e-05 | 198 | 214 | 10 | 3172_UP | |
| Drug | manganese | ENPP1 DARS1 RYR3 PNPT1 H3C1 GYG2 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S POLA1 POLRMT XPNPEP2 UPF2 ASL H3-3A PRKCI PKN1 | 1.97e-05 | 791 | 214 | 21 | CID000023930 |
| Drug | gadolinium | PDGFB RYR3 GHRHR CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 1.99e-05 | 199 | 214 | 10 | CID000023982 |
| Drug | bepridil | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 2.60e-05 | 126 | 214 | 8 | CID000002351 |
| Drug | amlodipine | CACNA1I CACNA1H KLK5 CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 2.60e-05 | 126 | 214 | 8 | CID000002162 |
| Drug | AC1NUZ8M | 2.62e-05 | 92 | 214 | 7 | CID000073211 | |
| Drug | pimozide | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 2.75e-05 | 127 | 214 | 8 | CID000016362 |
| Drug | AC1L1DXE | RYR3 CACNA1I CACNA1H DMPK CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A PPARGC1B PRKCI | 2.81e-05 | 299 | 214 | 12 | CID000002548 |
| Drug | AC1L1TJF | 3.65e-05 | 66 | 214 | 6 | CID000003377 | |
| Drug | riluzole | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 4.14e-05 | 174 | 214 | 9 | CID000005070 |
| Drug | nifedipine | SCD5 RYR3 CYP2W1 CACNA1I CACNA1H DMPK CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S CYP26B1 GRIN2A PRKCI | 4.15e-05 | 415 | 214 | 14 | CID000004485 |
| Drug | lanthanum | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 4.49e-05 | 136 | 214 | 8 | CID000023926 |
| Drug | phenytoin | PDGFB RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S COL6A3 | 4.50e-05 | 219 | 214 | 10 | CID000001775 |
| Drug | papaverine | ENPP1 RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S | 4.53e-05 | 176 | 214 | 9 | CID000004680 |
| Drug | Barium | 5.99e-05 | 72 | 214 | 6 | ctd:D001464 | |
| Drug | Landel | 6.60e-05 | 9 | 214 | 3 | CID000163838 | |
| Drug | baclofen | RYR3 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S GRIN2A | 8.52e-05 | 191 | 214 | 9 | CID000002284 |
| Drug | 11-ethylthioundecanoic acid | 8.79e-05 | 2 | 214 | 2 | CID000122099 | |
| Drug | tasosartan | 8.79e-05 | 2 | 214 | 2 | ctd:C086167 | |
| Drug | benziodarone | 8.79e-05 | 2 | 214 | 2 | ctd:C058702 | |
| Drug | tipranavir | 8.79e-05 | 2 | 214 | 2 | ctd:C107201 | |
| Drug | lead compounds | 8.97e-05 | 150 | 214 | 8 | CID000073212 | |
| Drug | AC1L3TPS | 9.36e-05 | 10 | 214 | 3 | CID000121952 | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 1.04e-04 | 196 | 214 | 9 | 5230_UP | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.04e-04 | 196 | 214 | 9 | 2783_UP | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 6026_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 5416_UP | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 214 | 9 | 6822_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 214 | 9 | 3608_DN | |
| Drug | Tetrandrine [518-34-3]; Up 200; 6.4uM; HL60; HT_HG-U133A | 1.21e-04 | 200 | 214 | 9 | 2520_UP | |
| Drug | leys | 1.28e-04 | 11 | 214 | 3 | CID000484683 | |
| Drug | chloroethyl | 1.42e-04 | 84 | 214 | 6 | CID000006338 | |
| Drug | fluo-3 | 1.58e-04 | 122 | 214 | 7 | CID000104978 | |
| Drug | AC1L2VU3 | 1.69e-04 | 12 | 214 | 3 | CID000129572 | |
| Drug | halothane | RYR3 CYP2W1 CACNA1I CACNA1H CACNA1B CACNA1C CACNA1D CACNA1F CACNA1S CYP26B1 PRKCI | 2.01e-04 | 314 | 214 | 11 | CID000003562 |
| Drug | Mibefradil | 2.18e-04 | 13 | 214 | 3 | ctd:D020748 | |
| Drug | remifentanil | 2.22e-04 | 32 | 214 | 4 | CID000060814 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 2.35e-09 | 4 | 207 | 4 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Williams Syndrome | 1.86e-05 | 8 | 207 | 3 | C0175702 | |
| Disease | Growth Deficiency and Mental Retardation with Facial Dysmorphism | 4.90e-05 | 2 | 207 | 2 | C1854630 | |
| Disease | Antihypertensive use measurement | USP38 CACNA1H NMT1 PREX1 SMG6 CACNA1C CACNA1D GTF2I KIAA0825 | 1.14e-04 | 265 | 207 | 9 | EFO_0009927 |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.16e-04 | 36 | 207 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 1.45e-04 | 15 | 207 | 3 | DOID:1928 (implicated_via_orthology) | |
| Disease | Progressive intrahepatic cholestasis (disorder) | 1.46e-04 | 3 | 207 | 2 | C0268312 | |
| Disease | Progressive familial intrahepatic cholestasis type 3 | 1.46e-04 | 3 | 207 | 2 | cv:C1865643 | |
| Disease | Cholestasis, benign recurrent intrahepatic 1 | 1.46e-04 | 3 | 207 | 2 | C4551899 | |
| Disease | intrahepatic cholestasis (is_implicated_in) | 2.91e-04 | 4 | 207 | 2 | DOID:1852 (is_implicated_in) | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 2.91e-04 | 4 | 207 | 2 | C4551898 | |
| Disease | Dystonia | 3.56e-04 | 86 | 207 | 5 | C0013421 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.89e-04 | 49 | 207 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Infiltrating duct carcinoma of female breast | 4.12e-04 | 21 | 207 | 3 | C3165106 | |
| Disease | muscular disease (implicated_via_orthology) | 4.83e-04 | 5 | 207 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Small cell carcinoma of lung | 5.65e-04 | 54 | 207 | 4 | C0149925 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 7.21e-04 | 6 | 207 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | GLIOMA SUSCEPTIBILITY 1 | 7.21e-04 | 6 | 207 | 2 | C2750850 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 8.67e-04 | 216 | 207 | 7 | EFO_0007925, EFO_0007927 | |
| Disease | apolipoprotein B measurement | GAS6 ARID1A ABCB4 DLG4 DOCK6 USP24 RCN1 BAZ1B PPP4R4 ABCB11 H3-3A ZFHX3 SYMPK | 8.73e-04 | 663 | 207 | 13 | EFO_0004615 |
| Disease | alpha 1-antitrypsin deficiency (implicated_via_orthology) | 1.00e-03 | 7 | 207 | 2 | DOID:13372 (implicated_via_orthology) | |
| Disease | Epileptic encephalopathy | 1.20e-03 | 30 | 207 | 3 | C0543888 | |
| Disease | Cholestasis of pregnancy | 1.33e-03 | 8 | 207 | 2 | C0268318 | |
| Disease | Cornelia De Lange Syndrome | 1.33e-03 | 8 | 207 | 2 | C0270972 | |
| Disease | benign neoplasm (implicated_via_orthology) | 1.33e-03 | 8 | 207 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | gallbladder neoplasm | 1.71e-03 | 9 | 207 | 2 | EFO_0004606 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.71e-03 | 9 | 207 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | cholestasis (implicated_via_orthology) | 1.71e-03 | 9 | 207 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.80e-03 | 181 | 207 | 6 | DOID:684 (is_implicated_in) | |
| Disease | angina pectoris | 1.92e-03 | 125 | 207 | 5 | EFO_0003913 | |
| Disease | colon cancer (is_implicated_in) | 2.05e-03 | 36 | 207 | 3 | DOID:219 (is_implicated_in) | |
| Disease | response to escitalopram, response to citalopram | 2.12e-03 | 10 | 207 | 2 | EFO_0006329, EFO_0007871 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.34e-03 | 257 | 207 | 7 | DOID:10652 (is_marker_for) | |
| Disease | primary biliary cirrhosis | 2.52e-03 | 133 | 207 | 5 | EFO_1001486 | |
| Disease | hypospadias | 2.58e-03 | 39 | 207 | 3 | EFO_0004209 | |
| Disease | FEV/FEC ratio | TRAF3IP1 PDGFB SCARF2 MRPS35 MAP1LC3A DENND5A MPP7 SMG6 CACNA1D COL6A3 SOX30 PDHX PPARGC1B GTF2I HMCN1 ARHGAP12 ZFHX3 CAPZA3 | 2.67e-03 | 1228 | 207 | 18 | EFO_0004713 |
| Disease | vital capacity | PHACTR2 PDGFB RPS6KA1 ZBTB43 GFPT1 PNPT1 CAVIN4 SMG6 CACNA1S COL6A3 CYP26B1 TENT5A NOB1 PCDHAC1 GRIN2A HMCN1 ZFHX3 CHSY3 | 2.86e-03 | 1236 | 207 | 18 | EFO_0004312 |
| Disease | lung adenocarcinoma (is_marker_for) | 3.06e-03 | 85 | 207 | 4 | DOID:3910 (is_marker_for) | |
| Disease | cleft palate (is_implicated_in) | 3.09e-03 | 12 | 207 | 2 | DOID:674 (is_implicated_in) | |
| Disease | bipolar I disorder | 3.24e-03 | 141 | 207 | 5 | EFO_0009963 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 3.42e-03 | 43 | 207 | 3 | DOID:9261 (is_marker_for) | |
| Disease | liver cirrhosis (is_implicated_in) | 3.42e-03 | 43 | 207 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | Osteogenesis Imperfecta | 3.63e-03 | 13 | 207 | 2 | C0029434 | |
| Disease | sphingomyelin 18:1 measurement | 3.63e-03 | 13 | 207 | 2 | EFO_0010394 | |
| Disease | migraine disorder | 3.87e-03 | 357 | 207 | 8 | MONDO_0005277 | |
| Disease | cardiotoxicity, response to anthracycline-based chemotherapy | 4.22e-03 | 14 | 207 | 2 | EFO_0005257, EFO_1001482 | |
| Disease | response to hydrochlorothiazide, triglyceride measurement | 4.40e-03 | 47 | 207 | 3 | EFO_0004530, EFO_0005202 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | IZUMO3 BNC1 KCND2 DLG2 UNC79 SMG6 TRMT9B CACNA1D GRIN2A POMGNT2 ZFHX3 CAPZA3 PHACTR1 | 4.50e-03 | 801 | 207 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | glycerate measurement | 4.84e-03 | 15 | 207 | 2 | EFO_0021029 | |
| Disease | osteoarthritis (implicated_via_orthology) | 4.84e-03 | 15 | 207 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 4.94e-03 | 49 | 207 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 4.97e-03 | 156 | 207 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Alzheimer disease, APOE carrier status | 5.08e-03 | 98 | 207 | 4 | EFO_0007659, MONDO_0004975 | |
| Disease | hearing impairment | 5.08e-03 | 98 | 207 | 4 | C1384666 | |
| Disease | QRS duration | 5.26e-03 | 298 | 207 | 7 | EFO_0005055 | |
| Disease | migraine without aura, susceptibility to, 4 | 5.51e-03 | 16 | 207 | 2 | MONDO_0011847 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 5.53e-03 | 51 | 207 | 3 | cv:CN043650 | |
| Disease | white matter hyperintensity measurement | 5.64e-03 | 302 | 207 | 7 | EFO_0005665 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 5.65e-03 | 101 | 207 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Antibody Deficiency Syndrome | 6.21e-03 | 17 | 207 | 2 | C0003257 | |
| Disease | Limb Deformities, Congenital | 6.21e-03 | 17 | 207 | 2 | C0206762 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 6.21e-03 | 17 | 207 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | spinal stenosis | 6.21e-03 | 17 | 207 | 2 | EFO_0007490 | |
| Disease | Metastatic melanoma | 6.49e-03 | 54 | 207 | 3 | C0278883 | |
| Disease | migraine disorder, systolic blood pressure | 6.96e-03 | 18 | 207 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | cD177 antigen measurement | 6.96e-03 | 18 | 207 | 2 | EFO_0021866 | |
| Disease | protein Z-dependent protease inhibitor measurement | 6.96e-03 | 18 | 207 | 2 | EFO_0021849 | |
| Disease | Myeloid Leukemia | 6.96e-03 | 18 | 207 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 6.96e-03 | 18 | 207 | 2 | C0023466 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRIIKETQRLLAEPV | 6 | P61088 | |
| VIPIRRAPLRSKIEI | 11 | P58557 | |
| RAPLRSKIEIVRRIL | 16 | P58557 | |
| IRTKDGIRLNLILIR | 91 | Q7L211 | |
| VRLVKRDVRTPLAVE | 91 | Q86TX2 | |
| RRQIRIREVNGIKPF | 296 | Q6PI77 | |
| ALRKILRRDLPVTRT | 251 | Q96KX2 | |
| RVKALTRNVPVRDIP | 1396 | Q86US8 | |
| APRIKRPRLQVVKRL | 96 | Q8WVB6 | |
| AVFRPKIRINLREVQ | 371 | Q96N23 | |
| RPQRQKAVRVAILVT | 251 | P32302 | |
| LVKRQIKRLEEPSLR | 416 | O00429 | |
| RRQPVRVLSLFEDIK | 186 | Q9UJW3 | |
| RARLPEELRSLVQKR | 511 | Q9UIG0 | |
| RRAVIILRKTRLDAP | 276 | Q6P6C2 | |
| VERTVRQLERVLKQP | 326 | Q9BX10 | |
| LLIIRSLRQGLRVEK | 241 | Q13304 | |
| TQAIPVRLKILLDRL | 101 | Q01954 | |
| RPVLRKIEEVRAILR | 231 | Q8TAV3 | |
| RVAIARALIRNPKIL | 566 | O95342 | |
| RIAIARAIVRDPKIL | 1226 | O95342 | |
| KIRDRLPVNVRELSL | 161 | Q9BTE6 | |
| REDRTPLIKAVQLRQ | 96 | A6QL64 | |
| LRKPTTLRQCEVLIR | 266 | Q96AQ1 | |
| LRKPTTLRQCEVLIR | 266 | Q96LY2 | |
| KKVNRIRTRIVTPER | 216 | Q5BKX8 | |
| LRAVRVLRPLKLVSG | 191 | Q00975 | |
| QNPIKVLVRLRKRLS | 721 | Q569K6 | |
| PITAIREIKILRQLT | 746 | Q14004 | |
| TIVVRKLIQKNVPRR | 91 | Q7Z4U5 | |
| RKVLVLFVVQRLEPR | 216 | Q9HBD1 | |
| VLRAKPTVRKERVVR | 26 | Q15293 | |
| RVKVRLIEDRVLPSQ | 251 | O95294 | |
| RVLPLRSLIQKLRVQ | 66 | Q6ZMN7 | |
| ILRRRKIEVSLQPEV | 381 | Q9H8H0 | |
| VEATQPVLKQRRRLT | 1646 | O14497 | |
| RKRRRLLSIIVVLVV | 241 | P35414 | |
| REDRTPLIKAVQLRQ | 96 | Q5JPF3 | |
| LQKEDTVRRLVLPAV | 946 | O75147 | |
| AISVVKILRVLRVLR | 961 | O60840 | |
| RDTKLIVVVRNPVTR | 196 | Q9Y278 | |
| VRRTQEALGKVIRRP | 6 | Q8TDR0 | |
| FQVILEKQIRIPRSL | 471 | P41743 | |
| PLRVAEITKEQRLRR | 336 | Q96II8 | |
| EIRDKATRRRLAVLP | 36 | Q9ULX3 | |
| RKRTPQLRLDVTTIL | 681 | Q8IV33 | |
| SKRVAPVLIREITRR | 256 | P30419 | |
| LRSKRVAPVLIREIT | 256 | O60551 | |
| VAPVLIREITRRVNL | 261 | O60551 | |
| KERLVPREVPRRVIN | 196 | Q09327 | |
| LLIRKLPFQRLVREI | 61 | P84243 | |
| RLLEVRKRINVLPLG | 186 | P04424 | |
| RPLIRVTGAENVRKI | 91 | Q9NR63 | |
| KAICRVLSIPVRVLV | 421 | O94919 | |
| TPVKRILQLTRAVQE | 6 | P54868 | |
| LLIRKLPFQRLVREI | 61 | Q5TEC6 | |
| LIRKLPFQRLVREIA | 61 | Q6NXT2 | |
| QVPDVEKRRRLLESL | 196 | Q96BY2 | |
| VQLRPVQVRKIEIVR | 146 | P01127 | |
| TEIPASNIRRVIAKR | 276 | O00330 | |
| LRRQDPQLKGIVTRL | 61 | Q92915 | |
| RRPEILVQPLKVSNR | 301 | Q5T2T1 | |
| VVVRRIRASSPRVLL | 176 | Q86UT5 | |
| PRQERKRTQDALIVL | 31 | Q9NZV8 | |
| PVIDRKRLLQLVREN | 1546 | Q5S007 | |
| KPKIRERRLQRVTAT | 406 | P0C6S8 | |
| QSPRKVLQEVRRVLR | 151 | Q6UX53 | |
| KLEVVDKRNPRLIRV | 301 | Q8NA19 | |
| DKRNPRLIRVATIVD | 306 | Q8NA19 | |
| KRRVIRNQEILIPTH | 816 | P22413 | |
| KILPLLASLQRIRVR | 1231 | Q9UGL1 | |
| LIKLNRRIRPTKDVR | 156 | Q9Y337 | |
| DKVGLVLRVLRALRI | 336 | Q9UIX4 | |
| PDRLVIRKLRATIRN | 501 | Q9Y4A0 | |
| REPLKVVLRQVVVSR | 516 | Q2VPB7 | |
| KLVRRLSQRPTTEEL | 516 | O75167 | |
| KVDIPSLIQTIRRVV | 451 | Q8NAT1 | |
| EKRAIPRRIADQVRL | 281 | Q9UL42 | |
| LLIRKLPFQRLVREI | 61 | P68431 | |
| VSPKVRKVLQLLRLR | 101 | P18124 | |
| QATPLELKAIEVLRR | 341 | Q16795 | |
| PIVVRLKEVRLQRDD | 56 | Q09013 | |
| LPREIRKLVERRKQV | 911 | P09884 | |
| LIEQNRKIIAPLVTR | 406 | O00469 | |
| IIKSRSLDRRLQEPI | 401 | Q8IWW6 | |
| QEPRQRVAAVKDLIR | 756 | Q8IWW6 | |
| RIIRAKITNVPRSLG | 4906 | Q96RW7 | |
| IAIARALVRNPKILL | 541 | P21439 | |
| RRQRELSILPKVTLE | 6 | Q9BPV8 | |
| IKRRLTRKLSQRPTV | 496 | Q9C0D0 | |
| QRPTVEELRERKILI | 506 | Q9C0D0 | |
| DVRRRIPIKLISKQA | 21 | Q75N03 | |
| VSRQRVESLRKKRPL | 196 | Q9BZ23 | |
| ARLVLPTDAVKQRVV | 621 | Q9H158 | |
| RHRLTRKLVVLITPQ | 61 | O15488 | |
| RLAPKVDVRVVILVS | 141 | Q9H1X3 | |
| KPRLEEQRIKLIVRI | 3211 | Q9C0G6 | |
| ATRVPRVQEVLLKAV | 386 | Q9Y4L1 | |
| INVVKILRVLRVLRP | 1011 | Q13936 | |
| LRRLRPVTAQLKIDI | 486 | Q96HP0 | |
| QLRRGIEKLRVRIEA | 2116 | P49454 | |
| VNKTGLVRPQELRRV | 186 | Q5THR3 | |
| SVVKILRVLRVLRPL | 891 | Q13698 | |
| PVRLARTVVVGKRQD | 516 | Q8TF40 | |
| VIRLRFKRLQPTRLV | 306 | Q14393 | |
| AIRTVRVLRPLKAIN | 176 | Q9P0X4 | |
| EILRPRRTLQKKIEE | 671 | P01031 | |
| VRRLKLNTEVRSVGP | 161 | P29322 | |
| ISRRTILIERKQGLI | 716 | Q4G0X9 | |
| RQQLRRKVVEILPDF | 896 | Q8NCU4 | |
| RIVRRLNIGPSKVRV | 1461 | P12111 | |
| REVVCVKRLRPIVSN | 471 | P36894 | |
| SRIQENRKRVILPSI | 261 | Q6IS24 | |
| NLLVTRLRQKVLREP | 671 | Q2TAC2 | |
| RELRVTKRNILDVRP | 401 | Q6QEF8 | |
| SRVDKIRLLNVRTPT | 606 | Q6IQ26 | |
| SDIPVEFIRRNVKLR | 66 | Q6P1S2 | |
| RPRSLENVLEINKRI | 651 | P78352 | |
| LNIIRILVRKLEPAQ | 301 | Q02643 | |
| RIPVTRALQREALKI | 251 | Q9Y6X4 | |
| KRSLRSQIRVQRVPV | 271 | Q96P31 | |
| EQLLERVRRKVPALR | 111 | Q9ULV5 | |
| RRNVLQKRPVIVKVL | 196 | Q16666 | |
| VQLVRKLLIIISRPA | 266 | O60307 | |
| QIPDTRRELAELVKR | 11 | Q9HAF1 | |
| TTERAKIVIRELLPN | 101 | Q96P70 | |
| LRAVIVRVLRPQVTA | 476 | Q14204 | |
| TVVRQSPRRIKPVRI | 346 | Q03164 | |
| LRNRIRVAIILLKEG | 346 | Q8NCS7 | |
| VRRRRPILETVVEIK | 181 | Q15700 | |
| TVLRQAIAERIKPVL | 141 | P13639 | |
| TKLVIDVCVRRRVPR | 126 | A6NKP2 | |
| RKPTLILRTQLSVRV | 106 | Q9Y613 | |
| KVIVPQLKGRVQRRR | 306 | P48728 | |
| LVRVLLKGARPRVVN | 176 | Q96DZ5 | |
| IPRLERIVRGSNKIK | 626 | P78347 | |
| RFLPALRRQLVVLVK | 896 | O95180 | |
| IRRLDTPLLRISQEK | 611 | Q9P225 | |
| LSTIRLRPRQVLCEK | 166 | Q6NUJ5 | |
| LTRRLQVEPRLLSKQ | 156 | O00411 | |
| AISVVKILRVLRVLR | 976 | Q01668 | |
| IKLIVVVRNPVTRAI | 281 | Q9Y661 | |
| KRVNLAQVDRPRVDI | 1146 | Q9HC10 | |
| AVRPLSVQAEILKRL | 921 | Q12923 | |
| EKPLIRSQSLRVVKR | 216 | Q9H6H4 | |
| RKKLVRALFIVPRQR | 601 | Q9HAU5 | |
| RLRVLAVQQVVKLRT | 71 | Q5VZ72 | |
| QTLQPITLELRRRKI | 276 | Q9BVI0 | |
| ERKLILVQVIPVVAR | 386 | O14896 | |
| SPQERERKVAILILT | 1011 | Q6ZUA9 | |
| RLQRILRVRTVTEKI | 136 | Q6NXP2 | |
| ITKLIRRRPFRQIQV | 1241 | Q7Z2Y5 | |
| RPTVDELRDRKILIR | 486 | Q96KR7 | |
| IQITVRRKEPRQKIV | 291 | Q8TC99 | |
| PRARVVVLRVKLSSL | 166 | P82673 | |
| LKRRVRSVILVILLG | 121 | P59544 | |
| AELRRRRLQKLESPV | 601 | Q86TM6 | |
| LKFQRTPVRQSVRRI | 831 | Q6P4F7 | |
| QRELDVVLRTVIPKT | 176 | Q8IYL2 | |
| DRVPNVRVLLAKTLR | 876 | Q8TF05 | |
| ELTIIERPVRRSLKT | 26 | Q6NUP7 | |
| RREILETLIKGLQRL | 16 | Q06210 | |
| VSPRVKRPIENRILI | 281 | Q00889 | |
| RLKGNIRVIARVRPV | 441 | Q9BVG8 | |
| RLTDRLQVAIKVIPR | 51 | Q9P1W9 | |
| LLIRKLPFQRLVREI | 61 | Q71DI3 | |
| RRVLQSVKRRSLKVP | 366 | Q96QT6 | |
| LRLLVELNKIPTVRA | 156 | Q8TCU6 | |
| QVLRPEGVLQRKVLR | 696 | Q86YN6 | |
| NRTARIIDKPRIIEV | 361 | P49903 | |
| TERTIAKRLVLRRDP | 41 | Q9H633 | |
| FRILKLIVRRRNAPV | 81 | Q9ULL8 | |
| ALTTRFTKRVRIIEP | 266 | Q14940 | |
| LLVPVKELNVRFRDR | 211 | Q8NG04 | |
| IVDFERIRRALRTPK | 46 | Q96M53 | |
| RPLRVLIDLIQRTKD | 281 | Q9H2K8 | |
| PTIREIIKLLRLQAA | 16 | Q8WVM0 | |
| VTDLLADPVVRIQRK | 176 | Q86SK9 | |
| NRIRKIDQRVLEKLP | 136 | P51888 | |
| PDRVLVRVRDLTIQK | 41 | P14868 | |
| IERIPRLRRQKKIFS | 481 | Q16512 | |
| IIGEKRRRIQITILS | 821 | Q13017 | |
| PVVQEPRRIIIRKTE | 101 | Q01974 | |
| VKRRIENRILILPSV | 286 | Q13046 | |
| SELVKIIRRRLQLNP | 61 | Q9H492 | |
| KEILTSRIIDRSIRP | 126 | Q8TCS8 | |
| ADKRIPRIRIETRQA | 376 | Q9Y2L1 | |
| AVRRLLQVKPEQVLL | 66 | O94993 | |
| KTLLSRRVVDVSVPR | 296 | Q8IW75 | |
| LIAPRVAELSERKRR | 26 | Q70JA7 | |
| NLPERLLRERAIFKV | 371 | O75153 | |
| QVLLKNSRRIVLPDV | 61 | O43298 | |
| KEQIISVGPIRRKRL | 2071 | O75443 | |
| STLRRKGNIILIPER | 726 | Q7Z2D5 | |
| NRTARIIDKPRVIEV | 411 | Q99611 | |
| RPRTRITDDQLKILR | 2086 | Q86UP3 | |
| FIIVKLSPLRDRLVV | 101 | Q86XI8 | |
| QPRVTRKRLERELQE | 1926 | Q96T58 | |
| PRELSERKLVRNVRQ | 511 | Q9Y2P5 | |
| RVAVRIRPQLAKEKI | 11 | Q7Z4S6 | |
| EENASVVVKLLIRRP | 2211 | Q15413 | |
| RDKRVLALEILPERV | 91 | Q56A73 | |
| ILEEIKQERRLRPVR | 346 | Q8WWL2 | |
| RIPLRRQKLPKVVVA | 506 | Q96GP6 | |
| VARVEIKDVRIPVQL | 186 | Q8TAV4 | |
| PRINDIKRIIQSRER | 746 | Q14683 | |
| VPLTFLLVDRKLQRV | 231 | O75679 | |
| VRRKILDNVSLPLVL | 776 | Q8NB14 | |
| RRLTEEFQNVRIIKP | 206 | Q9UI43 | |
| IADIKRTVLRVIEQP | 816 | Q92797 | |
| LKRLVSRRLKVPEEQ | 26 | Q8N7F7 | |
| NVDFARILKRITVPR | 76 | Q3LFD5 | |
| RLTLKEQPRQVRVSL | 421 | Q9UDY6 | |
| NLEEPRITLRVRKLL | 1091 | Q9UPU5 | |
| RITLRVRKLLLLIPT | 1096 | Q9UPU5 | |
| LDESTLRKQIERVRP | 256 | Q9P272 | |
| LRKQIERVRPLKNTE | 261 | Q9P272 | |
| NVDFTRILKRITVPR | 76 | Q9UMW8 | |
| IREKVGPELQRRQLL | 621 | O43895 | |
| QPSLIVKVVRRRLAE | 96 | Q96IP4 | |
| RPERRTKEQILELLV | 76 | O95125 | |
| RILLPIVQKARRAIL | 171 | Q5FWF4 | |
| KRPRTRITDDQLRVL | 2146 | Q15911 | |
| IQIVPRQRKQRKIAV | 1831 | Q9P2D8 | |
| PIESSILAQRRVRKL | 716 | Q15418 | |
| RARLIPIIVLLLQKA | 706 | B0I1T2 | |
| RLLQLRTAEPEVRAK | 1696 | Q13402 | |
| QVHPRLVVIVLNKDR | 356 | Q12879 |